Qualitative analysis of COVID-19 experiences with testing and vaccination among people with systemic lupus erythematosus in the USA
Interventions may be implemented at multiple levels to address barriers to COVID-19 testing and vaccination among SLE patients. Clear and comprehensive guidelines for those with SLE, as well as efforts to enhance structural competency among providers, including a greater understanding of COVID-19 experiences in the context of SLE, may support protective behaviors in this patient population. Key Points • Accurate and up-to-date information from healthcare providers and other trusted sources that is tailored for SLE patients can facilitate testing and vaccination in response to novel infectious disease. • Many SLE patients displayed resilience and drew from sources of support in response to unique challenges during the COVID-19 pandemic.
Authors
- Catanya Stager (ORCID: https://orcid.org/0000-0002-5604-6310)
- Allyson G. Hall (ORCID: https://orcid.org/0000-0002-4945-9184)
- David H. Chae (ORCID: https://orcid.org/0000-0002-3674-447X)
- Lori Brand Bateman (ORCID: https://orcid.org/0000-0003-4705-165X)
- Somaia Khamess (ORCID: https://orcid.org/0000-0003-0862-0004)
- Candace H. Feldman (ORCID: https://orcid.org/0000-0002-4980-9770)
- Maria I. Danila (ORCID: https://orcid.org/0000-0001-9246-6200)
Institutions
- Tulane University (US)
- Brigham and Women's Hospital (US)
- Johns Hopkins University (US)
- Johns Hopkins Medicine (US)
- University of Alabama at Birmingham (US)
Publication Details
- Journal
- Clinical Rheumatology
- Published
- 2025-11-21
- DOI
- https://doi.org/10.1007/s10067-025-07814-0
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00